Skip to main content
. Author manuscript; available in PMC: 2019 Jun 1.
Published in final edited form as: Nanomedicine. 2018 Apr 14;14(4):1381–1394. doi: 10.1016/j.nano.2018.04.008

Figure 4.

Figure 4

A. Bioluminescence imaging of Ovcar8-IP tumors. Tumors treated with cisplatin emit noticeably weaker signal than siTWIST or siQ only control mice, while those treated with siTWIST-MSNs plus cisplatin exhibit a further loss of signal. siTWIST-MSN-HAs plus cisplatin exhibit a greatest loss of signal. B. Quantification of bioluminescence for all seven weeks of treatment as depicted in A for weeks 1 and 7. Units for luminescence are photons/sec/cm2/steradian.